AFRICA

🔒
❌ About FreshRSS
There are new articles available, click to refresh the page.
Before yesterdayYour RSS feeds

Next few weeks will see massive ramp-up in SA’s vaccine rollout

May 3rd 2021 at 12:16

Despite a slow start and the on-again-off-again Covid-19 vaccine rollout, experts have expressed faith in South Africa’s ability and infrastructure to ramp up inoculations but will need to optimally utilise both public and private resources.

To date, 318,670 healthcare workers have been vaccinated since the distribution of the Johnson & Johnson vaccine under the Sisonke Study, but this was temporarily halted following reports of a rare clotting condition.

ALSO READ: 300,000 Pfizer vaccines arrive in South Africa

The first batch of 325,260 doses of Pfizer vaccines arrived in the country on Monday morning, with approximately the same number of doses expected to land on a weekly basis to a total of over 1.3 million doses by the end of May.

Thereafter, the vaccine supply will increase to an average of 636 480 doses weekly from 31 May, which the health department said will see SA accumulating close to 4,5 million doses by the end of June.

Though the Johnson & Johnson vaccine roll-out was considered slow despite it being a single dose, public health experts believe SA was equipped to roll out the double-dose Pfizer vaccine.

Private sector must come to the party

“We do have enough infrastructure if we treat the health system as a whole and utilise public and private facilities including pharmacies as delivery modes,” public health specialist Dr Atiya Mosam said. “However, this decentralised approach will need to be carefully planned to ensure consistent and efficient delivery.”

She added that rural and underserved areas where facilities were few and far between would need alternative delivery platforms to ensure that they were not left behind.

ALSO READ: Cabinet welcomes decision to end Johnson and Johnson vaccine suspension

Public health expert and researcher Dr Shakira Choonara believes SA has amassed significant experience in rolling out vaccines in previous immunisation programmes.

“I do not foresee that there will be challenges. These past few months may have provided insights into teething problems. Once we have the supply and if government keeps to their end of the bargain (ensure registration and implementation), we should be able to rollout the vaccine,” she said.

Choonara added that it would also be critical to keep track of vaccine hesitancy.

After landing at OR Tambo International Airport, the Pfizer batch was transported to a central warehouse under heavy security coordinated by the National Joint Operational and Intelligence Structure (Natjoints).

Samples will then be sent to the National Control Laboratory for quality assurance and, after release, will be distributed to the provinces.

Health Minister Dr Zweli Mkhize said they had been notified that the Johnson & Johnson doses still awaiting dispatch in Gqeberha in the Eastern Cape were expected to be released around the middle of May.

He said the consignment was held due to a protracted safety verification process with international regulatory agencies (the Food and Drug Administration, European Medicines Agency and the South African Health Products Regulatory Authority) in the wake of the adverse findings during inspection of Emergent BioSolutions Bayview facility in the United States, one of the manufacturing partners of Johnson & Johnson.

“In the meantime, we will continue to vaccinate our healthcare workers with the remaining early access doses of Johnson & Johnson (through the Sisonke Protocol) and we will proceed to vaccinate with Pfizer,” the minister said in a statement.

Mkhize called on all healthcare workers, including traditional healers, and all citizens 60 years and above to register on the Electronic Vaccination Data System.

siphom@citizen.co.za

South Africa to get Russian and Chinese COVID-19 vaccines

April 28th 2021 at 07:58
South Africa plans to buy Russia’s Sputnik V vaccines and shots developed by China’s Sinopharm Group Co. Ltd as it steps up efforts to tackle the coronavirus.

Global Covid infections hit weekly record despite vaccinations

April 19th 2021 at 02:11
More people were diagnosed with Covid-19 during the past seven days than any other week since the start of the pandemic.

Experts warn of bleak Covid-19 reality for South Africa

April 18th 2021 at 01:59
Health experts have warned that Covid-19 is unlikely to leave South Africa any time soon as it is an airborne virus.

South Africa’s spats with J&J, Pfizer mask patent concerns

April 17th 2021 at 02:58
Pharmaceutical companies supplying South Africa with Covid-19 vaccines are pressing the country to stop trying to loosen patent protections related to the inoculations, a person familiar with the situation said.

Vaccine blood-clot side effect puts focus on immune reaction

April 14th 2021 at 02:06
Rare cases of clotting that have been seen with two Covid-19 vaccines have put the spotlight on an uncommon reaction that occurs when the body unleashes its immune firepower against blood platelets.

South Africa suspends COVID-19 vaccine rollout

April 13th 2021 at 14:12
Health Minister Zweli Mkhize has announced that South Africa will temporarily suspend its Johnson & Johnson COVID-19 vaccine rollout.

SA suspends rollout of Johnson & Johnson Covid-19 vaccine

April 13th 2021 at 13:20

 

Minister of Health Dr Zweli Mkhize says South Africa is “voluntarily suspending” its intended rollout of the Johnson & Johnson (J&J) Covid-19 vaccine, after the United States paused their rollout due to reported blood clots in recipients.

“We have determined to voluntarily suspend our rollout until the causal relationship between the development of clots and the Johnson and Johnson vaccine is sufficiently interrogated,” Mkhize said.

“Sahpra [South African Health Products Regulatory Authority] will collate information from Johnson & Johnson, the FDA [US Food and Drug Administration] and other regulatory bodies to make a thorough assessment of the situation and advise us,” Mkhize said.

ALSO READ: USA may ‘pause’ J&J vaccine use as SA awaits 30m doses

However, he intimated that there was no need to panic, saying these reports were expected and adding that no clots had been reported in South Africa, “and this is after having inoculated 289,787 healthcare workers under the Sisonke Protocol”.

Top US health authorities on Tuesday recommended a “pause” in the use of the vaccine “out of an abundance of caution” as they investigate any links between it and blood clots.

The news comes two weeks after President Cyril Ramaphosa confirmed that South Africa had secured 30 million J&J Covid-19 vaccines.

Mkhize, however, also announced that amid the intended rollout pause, South Africa had secured 10 million additional Pfizer vaccines, with two million due to be delivered next month – bring the secured Pfizer vaccines to 30 million doses.

“This also reassures us that, in the extremely unlikely event that Johnson & Johnson rollout is completely halted, we will not have any impediment to proceed with phase two of the rollout with Pfizer.

“We are confident that the rollout of Johnson & Johnson will resume and so, with 30 million doses of Johnson & Johnson and 30 million doses of Pfizer secured, we now have enough doses to exceed the 40 million we were targeting this year,” Mkhize said.

Watch the briefing below, courtesy of the SABC.

Additional reporting by AFP

WATCH: Mkhize briefs SA on Johnson & Johnson vaccine

April 13th 2021 at 13:05

Minister of Health Dr Zweli Mkhize is set to make an announcement on South Africa’s response to the United States’ temporary suspension of the Johnson & Johnson Covid-19 vaccine rollout.

Top US health authorities on Tuesday recommended a “pause” in the use of the vaccine “out of an abundance of caution” as they investigate any links between it and blood clots, US Food and Drug Administration (FDA) said.

UPDATE: SA suspends rollout of Johnson & Johnson Covid-19 vaccine

“CDC [Centers for Disease Control]  & FDA are reviewing data involving 6 reported U.S. cases of a rare & severe type of blood clot in individuals after receiving the vaccine. Right now, these adverse events appear to be extremely rare,” the FDA stated on Twitter.

Watch the briefing below, courtesy of the SABC.

Calls to pause Johnson & Johnson COVID-19 vaccine use over blood clotting concerns

April 13th 2021 at 07:51
U.S. health officials recommended a pause in the use of Johnson & Johnson’s COVID-19 vaccine on concerns about severe blood clotting.

Slow vaccine rollout means third-wave risk is still a reality in South Africa: economists

April 12th 2021 at 03:10
Despite Covid-19 data showing a relatively stable rate of infection a week after the Easter break, it's still too early to tell whether lockdown measures over the long weekend were effective or not.

Second phase of mass vaccination to begin on 17 May

April 9th 2021 at 01:07
By: SANews
Health minister Zweli Mkhize has announced that the second phase of the country’s vaccination roll-out will begin on 17 May.

Johnson & Johnson COVID-19 vaccine gets official approval in South Africa

April 1st 2021 at 10:52
Johnson & Johnson’s coronavirus vaccine has been approved by South African regulators for general use days after President Cyril Ramaphosa said the country will get more than 30 million doses.

How the investment landscape is changing in Asia

March 28th 2021 at 18:08
‘China was one of the few countries in the world to achieve GDP growth last year … without expanding their balance sheet’ – Charlie Dutton – portfolio manager, Ninety One.

Which is the best Covid vaccine to get? It’s complicated

March 15th 2021 at 02:39
As suppliers struggle to meet global demand, experts say the best vaccine for you is probably whichever one you can get now.

Government expects to vaccinate 65% of population

March 11th 2021 at 00:27
By: SANews
Health minister Zweli Mkhize says government remains committed to vaccinating 65% of the population, or 40 million people, by the end of the year to help the country reach herd immunity.
❌